Author

G. Gembillo

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

CAR-T Cell Therapy in Nephrology: Evidence Across Immune-Mediated Kidney Diseases and Plasma Cell Dyscrasias, Renal Toxicity, and Patient Monitoring

In many immune-mediated kidney diseases, tissue injury is driven by dysregulated B-cell immunity, with autoantibodies and complement acting as key effectors at the glomerulus. Corticosteroids and conventional immunosuppressants control these diseases only in part, and they do so at the price of cumulative toxicity and...

L. Visconti, L. Soraci, Lorenzo Lo Cicero et al. · Future Pharmacology · 0 citations

Open access Sep 2026

Diagnostic Accuracy and Alignment With Human Reader Responses Across Five Large Language Models on Complex Clinical Case Challenges

Introduction: Large language models (LLMs) match or exceed physician accuracy on benchmark diagnostic tasks. Whether higher accuracy reflects human-like diagnostic behavior, which bears on how safely clinicians can supervise these systems, is rarely assessed. Objectives: To determine whether diagnostic accuracy and al...

R. Bellocco, L. Soraci, Lorenzo Lo Cicero et al. · Epidemiology Biostatistics a... · 0 citations

Review Jul 2026

Angiotensin system modulation in focal segmental glomerulosclerosis: pharmacological basis and clinical implications.

INTRODUCTION FSGS is a histological convergence point for biologically distinct conditions: primary immune-mediated, genetic, and secondary adaptive forms, each with its own pharmacological logic. ACE inhibitors and angiotensin receptor blockers have anchored its management for three decades on evidence drawn predomina...

G. Gembillo, Chiara Casuscelli, A. L. La Spada et al. · Expert Opinion on Pharmacoth... · 0 citations